|
US 11,987,558 B1 |
|
ALK5 inhibitors and their uses |
Dori A. Thomas-Karyat, Short Hills, NJ (US) |
Assigned to Synthis Therapeutics, Inc., New York, NY (US) |
Filed by Synthis Therapeutics, Inc., New York, NY (US) |
Filed on Mar. 24, 2023, as Appl. No. 18/189,387. |
Application 18/189,387 is a division of application No. 18/146,269, filed on Dec. 23, 2022. |
Application 18/146,269 is a division of application No. 16/654,194, filed on Oct. 16, 2019, granted, now 11,583,593, issued on Feb. 21, 2023. |
Application 16/654,194 is a continuation of application No. 16/286,122, filed on Feb. 26, 2019, abandoned. |
Application 16/286,122 is a continuation of application No. 16/029,351, filed on Jul. 6, 2018, abandoned. |
Application 16/029,351 is a continuation of application No. 15/404,233, filed on Jan. 12, 2017, abandoned. |
Claims priority of provisional application 62/278,928, filed on Jan. 14, 2016. |
This patent is subject to a terminal disclaimer. |
Int. Cl. C07D 231/04 (2006.01) |